Content area

Abstract

(CCNMatthews - Aug. 25, 2005) - ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that results from an engineering optimization study conducted at the Cedars Breast Center of the Royal Victoria Hospital in Montreal, Quebec, Canada, under the supervision of Dr. David Fleiszer, have been published in the August issue of Academic Radiology. The article, entitled "Time-Domain Optical Mammography SoftScan(R): Initial Results", illustrates the sensitivity of near-infrared (NIR) optical techniques to the metabolic functions of breast tissue. Using the non-invasive SoftScan system, 49 women underwent tests resulting in statistically significant discrimination of malignant and benign tissue based on their deoxy-hemoglobin content.

Details

Title
ART Advanced Research Technologies Inc.: SoftScan Breast Cancer Imaging Device Featured in Academic Radiology Peer-Reviewed Journal
Pages
1
Publication year
2005
Publication date
Aug 25, 2005
Publisher
Intrado Digital Media Canada Inc.
Source type
Trade Journal
Language of publication
English
ProQuest document ID
448061219
Copyright
Copyright CCNMatthews Aug 25, 2005